ENTA—I have come up with a few models but it's difficult with the partnership structure to come up with a PPS target. What would be a reasonable PPS target on positive trial outcomes for ENTA?
I don’t have a specific price target, but I think it’s very clear that the share price is undervalued for the reasons stated in #msg-90536586 and the embedded links referenced in that post.
If you have valuation models on ENTA, please share them with the board. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”